EE493 Cost-Utility Analysis of Trastuzumab Deruxtecan Versus Treatment of Physician’s Choice in HER2-Positive Metastatic Breast Cancer in Chinese Setting
Abstract
Authors
S Hu G Fan
S Hu G Fan
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now